Drug Search Results
More Filters [+]

AU-101

Alternative Names: AU-101, AU101, AU 101
Latest Update: 2024-10-17
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: CAR-T,ERBB2

Novel Mechanism: Yes

Modality: Cell Therapy

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Aurora BioPharma
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for AU-101

Countries in Clinic: Australia

Active Clinical Trial Count: 2

Highest Development Phases

Phase 1: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ACTRN12624001334594

P1

Not yet recruiting

Healthy Volunteers

2025-06-01

ACTRN12624000562572

P1

Not yet recruiting

Healthy Volunteers

2025-01-03

Recent News Events